Gene Switch / Molecular Switch Market
完整報告名稱與涵蓋範圍
Gene Switch / Molecular Switch Market, Share & Trends Analysis Report, Distribution by Application Area (Management of Treatment Related Toxicity, Regulation of Gene Expression), Type of Target Therapy (CAR T Cell Therapy, Gene Therapy), Type of Payment Model Employed, By Region, and Segment Forecasts, 2024-2031
報告摘要
In 2023, the Gene Switch / Molecular Switch Market worldwide was assessed at USD 0.69 Bn. Analysts project it will expand to USD 1.44 Bn by 2031, at a CAGR of 9.9% spanning 2024 to 2031.
At its core, Gene Switch / Molecular Switch pertains to locations on genes that are capable of binding regulatory molecules to start the transcription and translation processes that result in the expression of that particular gene. Stakeholders across the healthcare landscape are mountingly turning to these solutions to meet contemporary demands.
Market momentum is underpinned by mounting interest in advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region poised to deliver the strongest growth trajectory through the forecast period, underpinned by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Gene Switch / Molecular Switch Market Snapshot
Chapter 4. Global Gene Switch / Molecular Switch Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: Type of Payment Model Employed Area Estimates & Trend Analysis
5.1. Type of Payment Model Employed Area & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Payment Model Employed Area:
5.2.1. Management of Treatment Related Toxicity
5.2.2. Regulation of Gene Expression
5.2.3. Other Applications
Chapter 6. Market Segmentation 2: Type of Target Therapy Estimates & Trend Analysis
6.1. Type of Target Therapy & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Target Therapy:
6.2.1. CAR T Cell Therapy
6.2.2. Gene Therapy
6.2.3. Other Therapies
Chapter 7. Market Segmentation 3: Type of Payment Model Employed Estimates & Trend Analysis
7.1. Type of Payment Model Employed & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Payment Model Employed:
7.2.1. Upfront Payments
7.2.2. Milestone Payments
Chapter 8. Gene Switch / Molecular Switch Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed Area, 2024-2031
8.1.2. North America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Target Therapy, 2024-2031
8.1.3. North America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed, 2024-2031
8.1.4. North America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed Area, 2024-2031
8.2.2. Europe Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Target Therapy, 2024-2031
8.2.3. Europe Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed, 2024-2031
8.2.4. Europe Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed Area, 2024-2031
8.3.2. Asia Pacific Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Target Therapy, 2024-2031
8.3.3. Asia-Pacific Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed, 2024-2031
8.3.4. Asia Pacific Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed Area, 2024-2031
8.4.2. Latin America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Target Therapy, 2024-2031
8.4.3. Latin America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed, 2024-2031
8.4.4. Latin America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed Area, 2024-2031
8.5.2. Middle East & Africa Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Target Therapy, 2024-2031
8.5.3. Middle East & Africa Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed, 2024-2031
8.5.4. Middle East & Africa Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. aceRNA Technologies
9.2.2. Autolus Therapeutics
9.2.3. Bellicum Pharmaceuticals
9.2.4. Cellectis
9.2.5. Kiromic BioPharma
9.2.6. panCELLa
9.2.7. Precigen,
9.2.8. Sana Biotechnology
9.2.9. Sangamo Therapeutics
9.2.10. Editas Medicine
9.2.11. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們